Submit Content
Get the latest delivered to your inbox
Privacy Policy

Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. 

     Can Genomics Stop the World's Leading Cause of Death? Image

    POSTED 

    10-28-22

    Can Genomics Stop the World's Leading Cause of Death?

    For decades, cardiovascular disease has remained the number-one cause of death. In 2019 alone, nearly 18 million people around the world died from cardiovascular diseases (CVDs), which include disorders such as coronary heart disease, heart failure, and cerebrovascular disease. Most of these deaths ...
    Francis deSouza Recognized as 3BL Media's Responsible CEO of the Year for Innovation and ESG Integration Image

    POSTED 

    10-26-22

    Francis deSouza Recognized as 3BL Media's Responsible CEO of the Year for Innovation and ESG Integration

    Illumina CEO, Francis deSouza received the award for 3BL Media’s 2022 Responsible CEO of the Year: Innovation and ESG Integration.
    Illumina To Host Second Annual Virtual ESG Investor Event on Friday, October 28, 2022 Image

    POSTED 

    10-25-22

    Illumina To Host Second Annual Virtual ESG Investor Event on Friday, October 28, 2022

    Illumina announced that it will host its second annual virtual Environment, Social and Corporate Governance (ESG) focused investor event at 9:30 am Pacific Time (12:30 pm Eastern Time), Friday, October 28, 2022.
    Australia Begins a Big Push To Sequence Underserved Populations Image

    POSTED 

    10-21-22

    Australia Begins a Big Push To Sequence Underserved Populations

    Australia’s Centre for Population Genomics (CPG), a collaboration between the Garvan Institute of Medical Research and the Murdoch Children’s Research Institute, has launched a new initiative to engage diverse communities in genomic research.
    Illumina and GenoScreen Partner To Expand Access to Genomic Testing for Multidrug-Resistant Tuberculosis Image

    POSTED 

    10-20-22

    Illumina and GenoScreen Partner To Expand Access to Genomic Testing for Multidrug-Resistant Tuberculosis

    Illumina announced a partnership to accelerate progress to end tuberculosis (TB) worldwide. The partnership will expand capabilities for countries most impacted by tuberculosis to more effectively detect and combat multidrug-resistant TB (MDR-TB).
    Tracking COVID-19 With Dust at the Ohio State University Image

    POSTED 

    10-19-22

    Tracking COVID-19 With Dust at the Ohio State University

    When COVID-19 hit, most of The Ohio State University—home of the Buckeyes in the state capital of Columbus—shut down. But the Applied Microbiology Services Laboratory (ASML) within its Infectious Diseases Institute (IDI) stayed open.
    Boosting STEM Education in Bangladesh Image

    POSTED 

    10-18-22

    Boosting STEM Education in Bangladesh

    Illumina and the Illumina Corporate Foundation have provided a grant to the Child Health Research Foundation (CHRF), a Bangladeshi nonprofit that promotes public health and STEM education. The grant, worth over $300,000, includes cash and in-kind product.
    In Our DNA: Suzanne Rohrback, Senior Staff Bioinformatics Scientist at Illumina Image

    POSTED 

    10-17-22

    In Our DNA: Suzanne Rohrback, Senior Staff Bioinformatics Scientist at Illumina

    As a scientist on Illumina’s Assay Research team in San Diego, Suzanne Rohrback works with colleagues to come up with new ways next-generation sequencing (NGS) can maximize insights from a sample—such as cells from a tumor or a tube of blood—extracting as much information about it as possible, as ef...
    Illumina Launches Strategic Research Collaboration With AstraZeneca To Accelerate Drug Target Discovery Image

    POSTED 

    10-13-22

    Illumina Launches Strategic Research Collaboration With AstraZeneca To Accelerate Drug Target Discovery

    Illumina announced a strategic research collaboration with AstraZeneca, a global, science-led biopharmaceutical company, to accelerate drug target discovery by combining their strengths in artificial intelligence (AI) based genome interpretation and genomic analysis techniques along with industry ex...
    UC San Diego Students Cross Borders and Explore New Fields in STEM Image

    POSTED 

    10-12-22

    UC San Diego Students Cross Borders and Explore New Fields in STEM

    Growing up in Tijuana, Mexico, Olivia Graeve was interested in pursuing the sciences but didn’t quite know how to make a career of it. To her knowledge, no cross-border student exchange programs for scientific research were available to her.
    Illumina logo

    Illumina

    Illumina

    Join today and get the latest delivered to your inbox